Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives
Authors:
Open Access
- 22 March 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Abstract
Diabetic retinopathy (DR) is a significant cause of vision loss and a research subject that is constantly being explored for new mechanisms of damage and potential therapeutic options. There are many mechanisms and pathways that provide numerous options for therapeutic interventions to halt disease progression. The purpose of the present literature review is to explore both basic science research and clinical research for proposed mechanisms of damage in diabetic retinopathy to understand the role of triglyceride and cholesterol dysmetabolism in DR progression. This review delineates mechanisms of damage secondary to triglyceride and cholesterol dysmetabolism vs. mechanisms secondary to diabetes to add clarity to the pathogenesis behind each proposed mechanism. We then analyze mechanisms utilized by both triglyceride and cholesterol dysmetabolism and diabetes to elucidate the synergistic, additive, and common mechanisms of damage in diabetic retinopathy. Gathering this research adds clarity to the role dyslipidemia has in DR and an evaluation of the current peer-reviewed basic science and clinical evidence provides a basis to discern new potential therapeutic targets.Keywords
Funding Information
- Research to Prevent Blindness
This publication has 118 references indexed in Scilit:
- Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic miceNutrition & Diabetes, 2012
- Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathyDiabetic Medicine, 2012
- The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2Genes & Development, 2011
- Tyrosine Nitration of Prostacyclin Synthase Is Associated with Enhanced Retinal Cell Apoptosis in DiabetesThe American Journal of Pathology, 2011
- Neuroprotection from Retinal Ischemia/Reperfusion Injury by NOX2 NADPH Oxidase DeletionInvestigative Ophthalmology & Visual Science, 2011
- Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesNew England Journal of Medicine, 2010
- Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activitiesEuropean Journal of Pharmacology, 2010
- Targeting amyloid-β in glaucoma treatmentProceedings of the National Academy of Sciences, 2007
- Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathyBritish Journal of Ophthalmology, 2006
- High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in cultureBritish Journal of Ophthalmology, 2006